Ashton Thomas Private Wealth’s AstraZeneca AZN Stock Holding History

Ashton Thomas Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$457K	Buy	2,334 +81	+4%	+$15.6K	0.01%	747
2025 Q4	$414K	Buy	2,253 +428	+23%	+$75.1K	0.01%	718
2025 Q3	$280K	Buy	1,825 +314	+21%	+$47.5K	0.01%	823
2025 Q2	$211K	Sell	1,511 -162	-10%	-$22.7K	0.01%	792
2025 Q1	$246K	Buy	+1,673	New	+$242K	0.01%	714
2024 Q3	–	Sell	-1,003	Closed	-$156K	–	717
2024 Q2	$156K	Buy	+1,003	New	+$151K	0.01%	640
2023 Q3	–	Sell	-1,876	Closed	-$269K	–	566
2023 Q2	$269K	Buy	+1,876	New	+$276K	0.02%	501

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Ashton Thomas Private Wealth's AZN Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its AstraZeneca (AZN) stake by 3.6% in Q1 2026, buying an estimated $15.6K and bringing the position to 2,334 shares worth $457K. The position accounts for 0.01% of the portfolio, ranked #747.

Ashton Thomas Private Wealth first reported a position in AZN in Q2 2023 and has held it in 7 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Ashton Thomas Private Wealth held 2,334 shares of AstraZeneca worth $457K as of Q1 2026.
Ashton Thomas Private Wealth bought 81 AstraZeneca shares in Q1 2026, an estimated $15.6K.
AstraZeneca made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #747 holding.
Ashton Thomas Private Wealth first reported a position in AstraZeneca in Q2 2023 and has held it in 7 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.